FDA Approves Vyepti

FDA Approves Vyepti (eptinezumab-jjmr) Intravenous Injection for the Preventive Treatment of Migraine Valby, Denmark, February 22, 2020 – H. Lundbeck A/S today announced that Vyepti (eptinezumab-jjmr) has been approved by […]

» Read more
1 2 3 12